These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 12518053)

  • 1. Crystal structure of saposin B reveals a dimeric shell for lipid binding.
    Ahn VE; Faull KF; Whitelegge JP; Fluharty AL; Privé GG
    Proc Natl Acad Sci U S A; 2003 Jan; 100(1):38-43. PubMed ID: 12518053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystal structures of saposins A and C.
    Ahn VE; Leyko P; Alattia JR; Chen L; Privé GG
    Protein Sci; 2006 Aug; 15(8):1849-57. PubMed ID: 16823039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conformational dynamics of a lipid-interacting protein: MD simulations of saposin B.
    Stokeley D; Bemporad D; Gavaghan D; Sansom MS
    Biochemistry; 2007 Nov; 46(47):13573-80. PubMed ID: 17983243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression, purification, crystallization, and preliminary X-ray analysis of recombinant human saposin B.
    Ahn VE; Faull KF; Whitelegge JP; Higginson J; Fluharty AL; Privé GG
    Protein Expr Purif; 2003 Jan; 27(1):186-93. PubMed ID: 12510003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structures of the human ceramide activator protein saposin D.
    Popovic K; Privé GG
    Acta Crystallogr D Biol Crystallogr; 2008 May; 64(Pt 5):589-94. PubMed ID: 18453694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding of GM1 ganglioside to a synthetic peptide derived from the lysosomal sphingolipid activator protein saposin B.
    Champagne MJ; Lamontagne S; Potier M
    FEBS Lett; 1994 Aug; 349(3):439-41. PubMed ID: 8050611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding of GM1-ganglioside to a synthetic peptide derived from the lysosomal sphingolipid-activator-protein saposin B.
    Champagne MJ; Lamontagne S; Potier M
    FEBS Lett; 1994 Jun; 347(2-3):265-7. PubMed ID: 8034015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystal structure of saposin D in an open conformation.
    Gebai A; Gorelik A; Nagar B
    J Struct Biol; 2018 Nov; 204(2):145-150. PubMed ID: 30026085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of a mutation in a family with saposin B deficiency: a glycosylation site defect.
    Kretz KA; Carson GS; Morimoto S; Kishimoto Y; Fluharty AL; O'Brien JS
    Proc Natl Acad Sci U S A; 1990 Apr; 87(7):2541-4. PubMed ID: 2320574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acid sphingomyelinase possesses a domain homologous to its activator proteins: saposins B and D.
    Ponting CP
    Protein Sci; 1994 Feb; 3(2):359-61. PubMed ID: 8003971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional human saposins expressed in Escherichia coli. Evidence for binding and activation properties of saposins C with acid beta-glucosidase.
    Qi X; Leonova T; Grabowski GA
    J Biol Chem; 1994 Jun; 269(24):16746-53. PubMed ID: 8206997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal structures of human saposins C andD: implications for lipid recognition and membrane interactions.
    Rossmann M; Schultz-Heienbrok R; Behlke J; Remmel N; Alings C; Sandhoff K; Saenger W; Maier T
    Structure; 2008 May; 16(5):809-17. PubMed ID: 18462685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Saposins and their interaction with lipids.
    Vaccaro AM; Salvioli R; Tatti M; Ciaffoni F
    Neurochem Res; 1999 Feb; 24(2):307-14. PubMed ID: 9972880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Saposin fold revealed by the NMR structure of NK-lysin.
    Liepinsh E; Andersson M; Ruysschaert JM; Otting G
    Nat Struct Biol; 1997 Oct; 4(10):793-5. PubMed ID: 9334742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Porcine cerebroside sulfate activator (saposin B) secondary structure: CD, FTIR, and NMR studies.
    Waring AJ; Chen Y; Faull KF; Stevens R; Sherman MA; Fluharty AL
    Mol Genet Metab; 1998 Jan; 63(1):14-25. PubMed ID: 9538512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conformational and amino acid residue requirements for the saposin C neuritogenic effect.
    Qi X; Kondoh K; Krusling D; Kelso GJ; Leonova T; Grabowski GA
    Biochemistry; 1999 May; 38(19):6284-91. PubMed ID: 10320358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of carbohydrate removal on stability and activity of saposin B.
    Hiraiwa M; Soeda S; Martin BM; Fluharty AL; Hirabayashi Y; O'Brien JS; Kishimoto Y
    Arch Biochem Biophys; 1993 Jun; 303(2):326-31. PubMed ID: 8099782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural analysis of saposin C and B. Complete localization of disulfide bridges.
    Vaccaro AM; Salvioli R; Barca A; Tatti M; Ciaffoni F; Maras B; Siciliano R; Zappacosta F; Amoresano A; Pucci P
    J Biol Chem; 1995 Apr; 270(17):9953-60. PubMed ID: 7730378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of human saposins by NMR spectroscopy.
    John M; Wendeler M; Heller M; Sandhoff K; Kessler H
    Biochemistry; 2006 Apr; 45(16):5206-16. PubMed ID: 16618109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-resolution Crystal Structure of Human pERp1, A Saposin-like Protein Involved in IgA, IgM and Integrin Maturation in the Endoplasmic Reticulum.
    Sowa ST; Moilanen A; Biterova E; Saaranen MJ; Lehtiö L; Ruddock LW
    J Mol Biol; 2021 Mar; 433(5):166826. PubMed ID: 33453188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.